142 related articles for article (PubMed ID: 14710780)
1. Tolerance: is it achievable in pediatric solid organ transplantation?
Pearl JP; Preston E; Kirk AD
Pediatr Clin North Am; 2003 Dec; 50(6):1261-81, vii. PubMed ID: 14710780
[TBL] [Abstract][Full Text] [Related]
2. Prospects and strategies for clinical tolerance.
Monaco AP
Transplant Proc; 2004; 36(1):227-31. PubMed ID: 15013353
[TBL] [Abstract][Full Text] [Related]
3. Combinations of anti-LFA-1, everolimus, anti-CD40 ligand, and allogeneic bone marrow induce central transplantation tolerance through hemopoietic chimerism, including protection from chronic heart allograft rejection.
Metzler B; Gfeller P; Bigaud M; Li J; Wieczorek G; Heusser C; Lake P; Katopodis A
J Immunol; 2004 Dec; 173(11):7025-36. PubMed ID: 15557200
[TBL] [Abstract][Full Text] [Related]
4. The road to tolerance: renal transplant tolerance induction in nonhuman primate studies and clinical trials.
Elster EA; Hale DA; Mannon RB; Cendales LC; Swanson SJ; Kirk AD
Transpl Immunol; 2004; 13(2):87-99. PubMed ID: 15380539
[TBL] [Abstract][Full Text] [Related]
5. Donor chimera model for tolerance induction in transplantation.
Rezaee F; Peppelenbosch M; Dashty M
Hum Immunol; 2013 May; 74(5):550-6. PubMed ID: 23354322
[TBL] [Abstract][Full Text] [Related]
6. Blockade of the CD28/B7 pathway is required for the establishment of donor cell chimerism in CD40 ligand-deficient recipients.
Woodward JE; Zottola LB; Schaefer AT; Logar AJ; Stazer JK; Daskivich T; Peach R; Rao AS
Transplant Proc; 2001; 33(1-2):115. PubMed ID: 11266734
[No Abstract] [Full Text] [Related]
7. Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen.
Dodd-O JM; Ganguly S; Vulic A; Panoskaltsis-Mortari A; McDyer JF; Luznik L
Transplantation; 2016 Dec; 100(12):e140-e146. PubMed ID: 27861294
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment.
Wekerle T; Kurtz J; Ito H; Ronquillo JV; Dong V; Zhao G; Shaffer J; Sayegh MH; Sykes M
Nat Med; 2000 Apr; 6(4):464-9. PubMed ID: 10742157
[TBL] [Abstract][Full Text] [Related]
9. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
10. Conceptual shifts in immunology: comments on the "two-way paradigm".
Tauber AI
Theor Med Bioeth; 1998 Sep; 19(5):457-73. PubMed ID: 10023194
[No Abstract] [Full Text] [Related]
11. The changing immunology of organ transplantation.
Starzl TE; Demetris AJ; Murase N; Trucco M; Thomson AW; Rao AS
Hosp Pract (1995); 1995 Oct; 30(10):31-4, 37-42. PubMed ID: 7593387
[TBL] [Abstract][Full Text] [Related]
12. Transplantation tolerance, microchimerism, and the two-way paradigm.
Starzl TE; Demetris AJ
Theor Med Bioeth; 1998 Sep; 19(5):441-55. PubMed ID: 10023193
[No Abstract] [Full Text] [Related]
13. STEALTH in transplantation tolerance.
Hutchings A; Hubbard WJ; Thomas FT; Thomas JM
Immunol Res; 2002; 26(1-3):143-52. PubMed ID: 12403353
[TBL] [Abstract][Full Text] [Related]
14. Tolerance in heart transplantation: the Holy Grail, or an attainable goal?
Pierson RN
Heart Fail Clin; 2007 Jan; 3(1):17-29. PubMed ID: 17545006
[TBL] [Abstract][Full Text] [Related]
15. Immunologic tolerance for immune system-mediated diseases.
Hackett CJ; Dickler HB
J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):362-70. PubMed ID: 10069866
[TBL] [Abstract][Full Text] [Related]
16. Critical role of OX40 in CD28 and CD154-independent rejection.
Demirci G; Amanullah F; Kewalaramani R; Yagita H; Strom TB; Sayegh MH; Li XC
J Immunol; 2004 Feb; 172(3):1691-8. PubMed ID: 14734751
[TBL] [Abstract][Full Text] [Related]
17. Blockade of the CD28/B7 and CD40/CD40L costimulatory pathways does not ameliorate chronic rejection in a mouse aortic allograft model of direct antigen presentation.
Tang JL; Woodward JE; Subbotin V; Logar AJ; Sun H; Valdivia LA; Schaefer AT; Zottola LB; Peach R; Fung JJ; Rao AS
Transplant Proc; 2001; 33(1-2):382. PubMed ID: 11266872
[No Abstract] [Full Text] [Related]
18. Gene therapy-mediated CD40L and CD28 co-stimulatory signaling blockade plus transient anti-xenograft antibody suppression induces long-term acceptance of cardiac xenografts.
Hua N; Yamashita K; Hashimoto T; Masunaga T; Fujita M; Furukawa H; Uede T; Todo S
Transplantation; 2004 Nov; 78(10):1463-70. PubMed ID: 15599310
[TBL] [Abstract][Full Text] [Related]
19. The role of CD154 in organ transplant rejection and acceptance.
Kirk AD; Blair PJ; Tadaki DK; Xu H; Harlan DM
Philos Trans R Soc Lond B Biol Sci; 2001 May; 356(1409):691-702. PubMed ID: 11375072
[TBL] [Abstract][Full Text] [Related]
20. T-cell costimulatory pathways in allograft rejection and tolerance.
Clarkson MR; Sayegh MH
Transplantation; 2005 Sep; 80(5):555-63. PubMed ID: 16177624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
